Ranexa (Ranolazine) & Seizure

Basic Details
Status
Complete
Last Updated
Thursday, January 3, 2019
Health Outcome(s)
seizure
Purpose
Drug and Outcome Analysis
Regulatory Determination / Use

Combined with evidence from the Centers for Medicare & Medicaid Services, risk of seizure was determined to be driven primarily by underlying comorbidities. FDA decided that no action is necessary at this time, based on available information.